Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | -33.72%24.42M | -652.78%-995K | -91.39%2.98M | 850.19%21.94M | 315.02%501K | 141.23%36.85M | -96.58%180K | 371.91%34.6M | -4.35%2.31M | -186.62%-233K |
| Net profit before non-cash adjustment | 112.13%8.14M | 22.03%-32.54M | 98.28%-232K | 1,002.58%46.56M | 15.90%-5.65M | 45.30%-67.13M | 6.48%-41.73M | 52.49%-13.52M | 88.92%-5.16M | -118.01%-6.72M |
| Total adjustment of non-cash items | -140.96%-23.64M | -21.61%31.98M | -91.79%925K | -2,766.70%-57.81M | -63.31%1.28M | -13.88%57.71M | 136.30%40.79M | 273.77%11.27M | -95.10%2.17M | 39.12%3.48M |
| -Depreciation and amortization | -30.95%763K | 22.28%247K | -58.70%121K | -34.12%195K | -36.31%200K | -24.47%1.11M | -31.76%202K | 1.74%293K | -26.37%296K | -34.17%314K |
| -Reversal of impairment losses recognized in profit and loss | -30.23%33.57M | -13.15%33.41M | --0 | --151K | --0 | -8.31%48.11M | 408.75%38.47M | 644.67%9.15M | --0 | -35.08%483K |
| -Share of associates | -46.15%7K | --2K | -60.00%2K | 125.00%9K | -250.00%-6K | -43.48%13K | --0 | -28.57%5K | -20.00%4K | -33.33%4K |
| -Disposal profit | -27,773.89%-63M | -85,880.00%-4.3M | --0 | -26,459.28%-58.7M | --0 | 86.62%-226K | ---5K | --0 | 78.77%-221K | --0 |
| -Other non-cash items | -42.35%5.02M | 22.98%2.61M | -56.01%802K | -74.77%527K | -59.58%1.08M | -40.92%8.71M | -77.40%2.12M | -12.78%1.82M | 7.96%2.09M | 102.34%2.68M |
| Changes in working capital | -13.73%39.92M | -138.78%-434K | -93.80%2.29M | 526.23%33.19M | 62.10%4.88M | -34.82%46.27M | -96.57%1.12M | 12.42%36.84M | 11.96%5.3M | 253.47%3.01M |
| -Change in receivables | -8,372.91%-29.4M | -136.28%-8.23M | -18.52%-1.39M | -965.74%-19.69M | -104.92%-100K | 95.53%-347K | 65.71%-3.48M | -135.44%-1.17M | 326.72%2.27M | 2,290.59%2.03M |
| -Change in inventory | -106.08%-4.56M | -100.67%-482K | 200.97%2.29M | -895.10%-6.81M | -90.34%442K | 782.83%74.99M | 7,839.98%71.83M | -125.31%-2.27M | -15.73%857K | 908.30%4.58M |
| -Change in payables | 350.12%74.12M | 138.43%6.7M | 146.44%6.12M | 1,668.33%59.03M | 196.55%2.27M | -143.66%-29.63M | -136.85%-17.44M | -183.07%-13.18M | -41.15%3.34M | -136.59%-2.35M |
| -Changes in other current assets | -118.87%-238K | 103.16%1.57M | -108.87%-4.74M | 156.80%664K | 281.15%2.27M | -47.02%1.26M | -1,276.50%-49.79M | 1,056.11%53.47M | -22.79%-1.17M | -153.87%-1.25M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | ||||||||||
| Tax refund paid | 84.85%-20K | 155.56%5K | 73.08%-7K | 83.33%-8K | 79.59%-10K | 61.06%-132K | 90.82%-9K | 88.13%-26K | -269.23%-48K | -444.44%-49K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | -33.54%24.4M | -678.95%-990K | -91.41%2.97M | 870.01%21.93M | 274.11%491K | 145.82%36.72M | -96.69%171K | 386.08%34.57M | -5.83%2.26M | -208.46%-282K |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 1,800.44%4.28M | 85,900.00%4.3M | -1,700.00%-18K | -101.36%-3K | ---3K | -86.56%225K | 108.93%5K | -100.11%-1K | -77.17%221K | --0 |
| Net business purchase and sale | ---20.31M | --0 | --0 | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net investment product transactions | -70.59%2.25M | 64.38%-57K | -28.30%-68K | -69.51%2.39M | -180.00%-16K | 398.69%7.64M | 29.20%-160K | -47.22%-53K | 336.14%7.83M | 1,100.00%20K |
| Interest received (cash flow from investment activities) | 30.08%160K | 5.26%60K | 255.00%71K | -64.29%10K | 5.56%19K | -61.44%123K | -75.32%57K | -50.00%20K | -9.68%28K | 5.88%18K |
| Investing cash flow | -270.54%-13.62M | 4,490.82%4.3M | 55.88%-15K | -321.62%-17.91M | --0 | 126.61%7.99M | -92.16%-98K | -103.82%-34K | 189.16%8.08M | 134.55%38K |
| Financing cash flow | ||||||||||
| Net issuance payments of debt | 84.43%-5.59M | -121.16%-577K | 92.39%-2.49M | 64.22%-2.97M | -81.45%442K | -323.98%-35.9M | 277.42%2.73M | -473.82%-32.72M | -435.47%-8.29M | 644.69%2.38M |
| Increase or decrease of lease financing | --0 | --0 | --0 | --0 | --0 | 65.85%-111K | --0 | 40.00%-39K | 39.24%-48K | 81.25%-24K |
| Interest paid (cash flow from financing activities) | 41.43%-5.18M | -4.05%-2.67M | 40.57%-873K | 74.63%-537K | 59.15%-1.1M | -6.46%-8.85M | 26.92%-2.57M | 15.67%-1.47M | -23.37%-2.12M | -101.12%-2.7M |
| Net other fund-raising expenses | ---- | ---- | ---- | ---- | ---- | --175K | --0 | --0 | --0 | --175K |
| Financing cash flow | 75.89%-10.77M | -2,143.40%-3.25M | 90.17%-3.36M | 66.49%-3.5M | -309.32%-659K | -161.24%-44.68M | 103.12%159K | -355.81%-34.23M | -212.71%-10.45M | 85.98%-161K |
| Net cash flow | ||||||||||
| Beginning cash position | 1.88%-1.3M | 11.40%-1.36M | 48.32%-953K | 15.12%-1.47M | 1.88%-1.3M | 50.58%-1.33M | -14.72%-1.54M | -0.66%-1.84M | 52.97%-1.73M | 50.58%-1.33M |
| Current changes in cash | -72.00%7K | -72.41%64K | -231.72%-407K | 566.67%518K | 58.52%-168K | -98.16%25K | 2,220.00%232K | -37.45%309K | -105.99%-111K | 59.42%-405K |
| End cash Position | 0.54%-1.3M | 0.54%-1.3M | 11.40%-1.36M | 48.32%-953K | 15.12%-1.47M | 1.88%-1.3M | 1.88%-1.3M | -14.72%-1.54M | -0.66%-1.84M | 52.97%-1.73M |
| Free cash flow | -33.60%24.38M | -678.95%-990K | -91.46%2.95M | 869.88%21.93M | 273.05%488K | 151.64%36.72M | -96.65%171K | 388.19%34.57M | -2.42%2.26M | -431.76%-282K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.